The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...
The once-high-flying firm has been beset by challenges since going public via a SPAC merger in 2021. Here’s the latest.
Me announced on Monday it would cut approximately 40% of its workforce, impacting over 200 employees. The restructuring ...
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
23andMe, a leading name in the genetic testing business, has revealed plans to lay off some 200 employees ... The breached ...
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
23andMe Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, ...